Research report on anti-HBV drug market
Under the joint impact of four anti-HBV nucleoside drugs, i.e. lamivudine, adefovir dipivoxil, entecavir and Telbivudine, from 2001~2006, anti-HBV market of China’s sample hospitals in key cities grew at a speed of more than average 30%. It is no doubt that China’s anti-HBV drug will continue to develop rapidly in a period of time in the future. This report mainly classifies the current anti-HBV drugs, and analyzes the most important types of anti-HBV drug markets and demand markets.
1. BRIEF INTRODUCTION AND CLASSIFICATION OF ANTI-HBV DRUG
2. SCALE ANALYSIS OF ANTI-HBV DRUG MARKET
3. ANTI-HBV-VIRUS TYPE HBV TREATMENT DRUG
4. IMMUNE REGULATION TYPE HBV TREATMENT DRUG
5. HBV TREATMENT DRUG THAT IMPROVE LIVER CELL FUNCTION
6. DEMAND MARKET ANALYSIS OF ANTI-HBV DRUG
2. SCALE ANALYSIS OF ANTI-HBV DRUG MARKET
3. ANTI-HBV-VIRUS TYPE HBV TREATMENT DRUG
4. IMMUNE REGULATION TYPE HBV TREATMENT DRUG
5. HBV TREATMENT DRUG THAT IMPROVE LIVER CELL FUNCTION
6. DEMAND MARKET ANALYSIS OF ANTI-HBV DRUG
